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A bstract
A ll-trans retinoic acid  (A TRA ) treatm ent of the ac-
ute prom yelocytic leukem ia (A PL ) have subse-
quently resulted  in  cell apoptosis, but the m ole -
cular m echanism  of this effect rem ains elusive. In  
order to understand a possible involvem ent of ge-
nes regulating apoptotic signal pathw ays, ex -
pression levels of bcl2 , bax , dapk1 , m yc , bad , wt1 , 
and m cl genes w ere analyzed during  A TR A  treat-
ment in five APL  patients with t (15;17) using Real- 
tim e PC R  (L ightC ycler). Tw o sam ples from  each  
patient were com pared to each other: prim ary dia -
gnostic sam ple and a sam ple taken at rem ission. 
Effect of the ATRA  treatm ent was dem onstrated by  
the concom itant induction of cd14  and il1β genes  
in  four patients. A lso other apoptosis related  ge-
nes w ere found dow n-regulated in  general but 
especially the dow n regulated  levels of w t1  and  
bax  attract attention . R esult suggested that ATRA  
dependent apoptosis o f A PL  w as under the con -
trol of both internal and external pathways without 
relationships to  the am ount o f the b last popul-
ations. Ratio of bcl2 to bax may be more important 
for th is regulation than the ratio  o f bcl2  to  bad . 
E ither bcl2  fam ily or less known apoptosis related  
genes as w t1  w ill still be required  to  further stu -
dies in  th is setting.
Keywords: APL; apoptosis; ATRA; gene expression; 
real-time PCR; t(15;17)
In troduction
All-trans retinoic acid (ATRA) dependent differentiation 
induction is used in the treatment of the acute pro-
myelocytic leukemia (APL) successfully. It has been 
clearly demonstrated in pre-clinical studies that cells 
induced to differentiate subsequently die via apoptosis 
(Martin et al., 199l; Gillis et al., 1995; Lo Coco et al., 
1998).
  Apoptosis might be induced by external signals at 
the surface of the cell. Fas and the TNF receptors 
transmit a signal to the cytoplasm that leads to 
activation of caspase 8. Myc expression can activate 
this signalling pathway prematurely (Hoffman et al., 
2002). In the second mechanism, a group of bcl2 
family proteins protect or initiate apoptosis. The pro- 
and anti-apoptotic bcl2 proteins can make hete-
rodimers and the ratio of these determines the ex-
ecution of cell death. Among these members bcl2 is 
anti-apoptotic while bax and bad are pro-apoptotic 
(Oltvai et al., 1993; Adams and Cory, 1998; Srivas-
tava et al., 1999; Mitchell et al., 2000; White et al., 
2001).
  Mcl1 is also described as a differentiation-related 
mitochondrial anti-apoptotic factor related to erk signal 
transduction pathway. There may be other genes in 
different pathways leading to apoptosis which are not 
yet fully characterized. Among these genes, dapk1 is 
a potential mediator cell death, and over expression 
of wt1 may lead to apoptosis (Deiss et al., 1995;  
Townsend et al., 1999; Mitchell et al., 2000).
  Apoptosis has been traditionally studied by cha-
racteristic cleavage of DNA into nucleosomal frag-
ments. Unfortunately, this method is unable to help 
in studying different genes simultaneously and not 
very sensitive.
  In our study we analysed the expression of the 
apoptosis related genes during the ATRA treatment 
in five APL patients with t(15;17) using an extremly 
sensitive technique known as quantitative Real-Time 
PCR (LightCycler, Roche Diagnostics GmbH, Ger-
many). We have used SYBR Green I dye binding 
method and determined the expression levels of se-
ven apoptosis related genes (bcl2, bax, mcl1, dapk1, 
myc, bad and wt1). Differentiation effect of the ATRA
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 treatment was aimed to demonstrate by cd14 and IL1β 
genes. Two samples from each patient were com-
pared to each other: primary diagnostic sample in 
diagnosis and a sample taken at complete remission.
M ateria ls and M ethods
Our study was based on bone marrow aspirates from 
5 APL patients having t(15;17) and treated with ATRA 
(45 mg/m2, daily). Among of these patients, 4 were 
Fig ure  1 . (A) LightCycler assisted standard analysis of the studied genes. On line fluorescence curves of PCR amplifications and exponential
increases in fluorescence intensities are shown as a measurement for the quantity of amplified fragments. (B) Specific melting curve analysis
of the apoptosis related genes in our study. The melting peaks at 87oC for RPS9, 90oC for CD14, 86oC for IL1β  1, and seven apoptosis
related genes between 81oC to 92oC indicate the spesific products that melt at the different temperatures.
T a b le  1 . **Data of 5 acute promyelocytic leukemia t(15;17) patients.
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
Blast countPatient Age/sex BP WBC (109/L) Hb (g/d) S (m)at diagnosis
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
1 19 (F) bcr1/2  7,000 10 18% 14+
2 69 (F) bcr1/2  2,600 10 50% 16+
3 44 (M) bcr1/2  2,500  5.1 95% 47+
4 29 (M) bcr3 39,500  6.7 80% 12+
5  2 (M) bcr1/2 10,000  8 20% n.a.
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Abbreviations: BP, Breakpoint; W BC, W hite Blood Cells; Hb, Hemoglobine; S (m), Survival (months); n.a., Data is not available. **All patients
have been treated with ATRA 45 mg/m 2, daily.
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in adult (average age: 27) and 1 was in childhood 
age (2). Diagnosis of APL is based on FAB criteria's. 
All of the patients were positive for PML-RAR alpha 
fusion transcripts detected by RT-PCR (Table 1) The 
samples were obtained from the University of Istanbul 
and all the treatments have been performed between 
1998-2001. Mononuclear cells from bone marrow 
aspirates were isolated by ficoll-hypaque centrifuga-
tion. Total RNA was extracted by using guanidium 
thiocyanate-phenol-chloroform extraction method as 
previously described (Chomznsky et al., 1987). RNA 
samples were treated with DNase I and quantitative 
Real-time PCR was performed as we described 
previously (Savli et al., 2002; Savli et al., 2003). 
Primer sequences of the selected genes have been 
shown in Table 2. On line fluorescence curves of 
F ig u re  2 . Standart curve analysis of the serial dilutions of the RPS9 housekeeping gene (Slope: -2.701, Intercept:33.80, Error: 0.0349,
R: -1.00).
T a b le  2 . Primer sequences of selected genes.
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
rps9 housekeeping gene CGTCTCGACCAAGAGCTGA
GGTCCTTCTCATCAAGCGTC
monocyte differentiation CD14 antigen precursor GAGCCGCACAGGTTCCTG
GCTTGGGCAATGCTCAGTACC
il1β (Interleukin-1 beta precursor) GTGCTGAATGTGGACTCAATCC
TGACAGAGGAGGGTTTCTTAGAAC
bcl2 AGGAAGTGAACATTTCGGTGAC
GCTCAGTTCCAGGACCAGGc
bax (BCL2-associated X protein) TGCTTCAGGGTTTCATCCAG 
GGCGGCAATCATCCTCTG
mcl1 (Myeloid cell leukemia sequence 1) GATGATCCATGTTTTCAGCGAC
CTCCACAAACCCATCCCAG
dapk1 (Death-associated protein kinase 1) CAGTGTTGTTGCTCTAGGAAG
GGGACTGCCACAAATGATGAGC
Myc oncogene GGCAAAAGGTCAGAGTCTGG
GTGCATTTTCGGTTGTTGC
wt1 (Wilms tumour I) CTGTCCCACTTACAGATGCACAG
TCTTTTGAGCTGGTCTGAACGA
bad (Bcl2 antagonist of cell death) GAGTGAGCAGGAAGACTCCAGC
TCCACAAACTCGTCACTCATCC
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
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PCR amplifications and melting curve analysis were 
shown in Figure 1. Standart curve analysis of the 
serial dilutions of the RPS9 housekeeping gene was 
shown in Figure 2.
  Obtained gene expression values were normalized 
using a housekeeping gene in both patient and heal-
thy control groups. For this aim rps9 was used which 
belongs to a gene family accepted more reliable than 
either of the classical housekeeping genes, in human 
and mouse malignant cell lines (Bhatia et al., 1994; 
Zhong et al., 1999). A new software tool was used, 
named REST (relative expression software tool), and 
compared treated and non-treated samples of each 
patient. The mathematical model used is based on 
the PCR efficiencies and the crossing point deviation 
between the samples (Pfaffl et al., 2002).
R esu lts and D iscussion
Specific results were indicated that induction of the 
apoptosis related genes takes place in parallel with 
the induction of differentiation (Table 3). This is de-
monstrated by the concomitant induction of cd14 and 
IL1β genes in four of the five patients while myc was 
down-regulated. Myc is a well known oncogene who 
has many functions in the cell cycle and these find-
ings were suggested that external pathway of the 
apoptosis is involved in the regulation of ATRA depen-
dent affect on APL (Cole et al., 1986; Schumacher 
et al., 2001).
  It has been informed that ATRA can induce differ-
entiation and reduce intracellular bcl2 levels without 
altering the susceptibility to drug-induced apoptosis 
and ATRA seems to increase chemo sensitivity by 
down regulation of bcl-2 in cell line (Bruel et al., 1995; 
Hu et al., 1996; Ketley et al., 1997).
  ATRA can also down regulate bcl2 expression in 
native AML blasts for a subset of patients indepen-
dent of their FAB classification (Pisani et al., 1997). 
Here we demonstrated that bcl2 gene levels were 
down-regulated in four of the five patients and these 
findings were in concordance with the previous liter-
ature. Pro and anti-apoptotic bcl2 proteins can make 
heterodimers where the ratio determines the sensi-
tivity of leukemic cells to apoptosis. In some reports 
the bcl2 to bax ratio has been inversely related with 
drug induced apoptosis in vitro and clinical response 
to chemotherapy. (Martin et al., 1991; Banker et al., 
1997; Decaudin et al., 1997; Pepper et al., 1997; 
Adams and Cory, 1998; Meijerink et al., 1998; 
Hoffman et al., 2001).
  We found that bcl2 to bad ratios were 3.09, 0.04, 
15, 114, and 1.5 while bcl2 to bax ratios were 16, 
160, 17.6, 1.6, and 23.2 after the ATRA treatment, 
for patients 1 to 5 respectively. This suggests that the 
T a b le  3 . Validation of relative gene expression by quantitative fluorescent PCR.
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
AccessionChromos. *Ratio *Ratio *Ratio *Ratio *RatioGENES numberlocation patient 1 patient 2 patient 3 patient 4 patient 5(GenBank)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Myc oncogene 8q24 V00568 0.60 0.57 0.3 0.38 286
il1β 2q13-q21 K02770 5.7 4.9 34 0.98 30.4
 (interleukin-1 beta precursor)
monocyte differentiation 5q31.1 M86511 2.7 302 66 0.1 26.1
 CD14 antigen precursor
wt1 (Wilms tumour I) 11p13 NM 024426 0.65 0.0005 0.0 0.0008 1,341
mcl1 1q21 L08246 0.0001 2.4 0.08 0.15 2.9
 (Myeloid cell leukemia sequence 1)
bcl2 18q21.3 M14745 0.65 0.16 0.03 0.16 9.3
dapk1 9q34.1 P53355 0.69 0.78 0.02 0.98 42.5
 (Death-associated protein kinase 1)
bad 11q13.1 AK023420 0.21 3.4 0.002 0.0014 6.1
 (Bcl2 antagonist of cell death)
bax 19q13.3-q13.4 L22474 0.04 0.001 0.0017 0.1 0.4
 (BCL2-associated X protein)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
*Ratio: Observed expression of the genes in ATRA treated patient samples/genes in non treated patient samples (The levels of housekeeping
gene rps9 were used as internal controls for normalization of RNA quantity and quality differences in all samples)
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ratio of bcl2 to bax may be more important for reg-
ulation of ATRA dependent apoptosis in this setting 
than the ratio of bcl2 to BAD.
  Mcl1 gene ratios were found under-expressed in 
three patients (1, 3, and 4) while only slightly up- 
regulated in patients 2 and 5. Also, dapk1 expres-
sions were down regulated in patients 1, 2 and 3 but 
the ratios were very close to normal expression le-
vels. On the other hand, wt1 gene levels were ex-
tremely down-regulated in patients 2, 3, 4.
  ATRA dependent apoptosis of APL cells were ob-
served under the control of the both internal and 
external pathways without relationship to the amount 
of the blast populations. Our data was confirming the 
hypothesis that the ratio of bcl2 to bax determines 
the ATRA dependent apoptotic response. Either bcl2 
family or other less known apoptosis related genes 
as wt1 will still be required to study in larger groups.
A cknow ledgem ent
This study was supported by Istanbul University Re-
search Fund and University of Kocaeli Research Fund.
R eferences
Adams J, Cory S. The Bcl-2 protein family: arbiters of cell 
survival. Science 1998;281:1322-6
Banker DE, Groudine M, Norwood T, Appelbaum FR. Mea-
surement of spontaneous and therapeutic agent-induced 
apoptosis with Bcl-2 protein expression in acute myeloid 
leukemia. Blood 1997;89:243-55
Bhatia P, Taylor WR, Greenberg AH, Wright, JA. Comparison 
of glyceraldehyde-3-phosphate dehydrogenase and 28S- 
ribosomal RNA gene expression as RNA loading controls for 
northern blot analysis of cell lines of varying malignant 
potential. Anal Biochem 1994;216:223-6
Bruel A, Benoit G, De Nay D. Distinct apoptotic responses 
in maturation sensitive and resistant t(15;17) acute pro-
myelocytic leukemia NB4 cells. 9-cis retinoic acid induces 
apoptosis independent of maturation and Bcl-2 expression. 
Leukemia 1995;9:1173-84
Chomczynsky P, Sacchi N. Single step metod of RNA isola-
tion by acide guanidium thiocyonate-phenol chloroform ex-
traction. Anal Biochem 1987;152-66
Cole MD. The myc oncogene: its role in transformation and 
differentiation. Annual Rev Genet 1986;20:361-84
Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-XL 
antagonize the mitochondrial dysfunction preceding nuclear 
apoptosis induced by chemotherapeutic agents. Cancer Res 
1997;57:62-7
Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identi-
fication of a novel serine/threonine kinase and a novel 15-kD 
protein as potential mediators of the gamma interferon- 
induced cell death. Gene Dev 1995;9:15-30
Gillis JC, Goa KL. Tretinoin. A review of its pharmacodyna-
mic and pharmacokinetic properties and use in the mana-
gement of acute promyelocytic leukaemia. Drugs 1995;50: 
897-923
Hoffman B, Amanullah A, Shafarenko M, Liebermann DA. 
The proto-oncogene MYC in hematopoietic development and 
leukemogenesis. Oncogene 2002;21:3414-21
Hu ZB, Minden MD, McCulloch EA. Post-transcriptional re-
gulation of bcl-2 in acute myeloblastic leukemia: significance 
for response to chemotherapy. Leukemia 1996;10:410-6
Ketley NJ, Allen PD, Kelsey SM. Modulation of idarubicine- 
induced apoptosis in human acute myeloid leukemia blasts 
by all-trans retinoic acid, 1,25 (OH) 2 vitamin D3, and gra-
nulocyte-macrophage colony-stimulating factor. Blood 1997; 
90:4578-87
Lo Coco F, Nervi C, Avvisati G, Mandelli F. Acute promyelo-
cytic leukemia: a curable disease. Leukemia 1998;12:1866- 
80
Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to 
differentiate towards neutrophils subsequently die via apop-
tosis. Clin Exp Immunol 1990;79:448-553
Meijerink JPP, Mensink EJBM, Wang K, Sedlak TW, Slöetjes 
AW, de Witte T, Waksman G, Korsmeyer SJ. Hematopoietic 
malignancies demonstrate loss-of-function mutations of BAX. 
Blood 1998;91:2991-7
Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed 
JC, EI-Deiry WS. Bax is a transcriptional target and mediator 
of MYC-induced apoptosis. Cancer Res 2000;60:6318-25
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes 
in vivo with a conserved homolog, Bax, that accelerates pro-
grammed cell death. Cell 1993;74:609-19
Pepper C, Hoy T, Bentley DP. Bcl-2/Bax ratios in chronic 
lymphocytic leukaemia and their correlation with in vitro 
apoptosis and clinical resistance. Brit J Cancer 1997;76: 
935-8
Pfaffl MW , Horgan GW, Dempfle L. Relative expression soft-
ware tool (REST) for group-wise comparison and statistical 
analysis of relative expression results in real-time PCR. 
Nucleic Acids Res 2002;30:e36
Pisani F, Del Poeta G, Aronica G. In vitro down-regulation 
of bcl-2 expression by all-trans retinoic acid in AML blasts. 
Ann Hematol 1997;75:145-7
Pritchard-Jones K, King-Underwood L. The Wilms tumour ge-
ne WT1 in leukaemia. Leukemia Lymphoma 1997;27:207-20
Savli H, Aalto Y, Nagy B, Knuutila S, Pakkala S. Gene 
expression analysis of 1,25 (OH) 2D3 dependent differen-
tiation of HL-60 cells: a cDNA array study. Brit J Haematol 
2002;118:1065-70
Savli H, Karadenizli A, Kolayli F, Gundes S, Ozbek U, 
Vahaboglu H. Expression stability of six housekeeping genes: 
a proposal for resistance gene quantification studies of 
Pseudomonas aeruginosa by real-time quantitative RT-PCR. 
J Med Microbiol 2003;52:403-8
Schuhmacher M, Kohlhuber F, Holzel M, Kaiser C, Burtscher 
H, Jarsch M, Bornkamm GW, Laux G, Polack A, Weidle UH, 
Eick D. The transcriptional program of a human B cell line 
Quantification of apoptotic genes in ATRA treated t (15;17) patients  459
in response to Myc. Nucleic Acids Res 2001;29:397-406
Srivastava RK, Sasaki CY, Hardwick JM, Longo DL. Bcl-2- 
mediated drug resistance: inhibition of apoptosis by blocking 
nuclear factor of activated T lymphocytes (NFAT)-induced 
Fas ligand transcription. J Exp Med 1999;190:253-65
Townsend KJ, Zhou P, Qian L, Bieszczad CK, Lowrey CH, 
Yen A, Craig RW. Regulation of MCL1 through a serum 
response factor/Elk-1-mediated mechanism links expression 
of a viability-promoting member of the BCL2 family to the 
induction of hematopoietic cell differentiation. The J Biol 
Chem 1999;274:1801-13
White MK, McCubrey JA. Suppression of apoptosis: role in 
cell growth and neoplasia. Leukemia 2001;15:1011-21
Zhong H, Simons JW. Direct comparison of GAPDH, beta- 
actin, cyclophilin, and 28S rRNA as internal standards for 
quantifying RNA levels under hypoxia. Biochem Bioph Res 
1999;259:523-6
